CVE-2014-5432

CVE-2014-5432 is a critical-severity vulnerability in Baxter Sigma Spectrum Infusion System Firmware with a CVSS 3.x base score of 9.8. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-287.

Key facts

Description

Baxter SIGMA Spectrum Infusion System version 6.05 (model 35700BAX) with wireless battery module (WBM) version 16 is remotely accessible via Port 22/SSH without authentication. A remote attacker may be able to make unauthorized configuration changes to the WBM, as well as issue commands to access account credentials and shared keys. Baxter asserts that this vulnerability only allows access to features and functionality on the WBM and that the SIGMA Spectrum infusion pump cannot be controlled from the WBM. Baxter has released a new version of the SIGMA Spectrum Infusion System, Version 8, which incorporates hardware and software changes.

Frequently asked questions

What is CVE-2014-5432?
Baxter SIGMA Spectrum Infusion System version 6.05 (model 35700BAX) with wireless battery module (WBM) version 16 is remotely accessible via Port 22/SSH without authentication. A remote attacker may be able to make unauthorized configuration changes to the WBM, as well as issue commands to access account credentials and shared keys. Baxter asserts that this vulnerability only allows access to features and functionality on the WBM and that the SIGMA Spectrum infusion pump cannot be controlled from the WBM. Baxter has released a new version of the SIGMA Spectrum Infusion System, Version 8, which incorporates hardware and software changes.
How severe is CVE-2014-5432?
CVE-2014-5432 has a CVSS 3.x base score of 9.8, rated critical severity. It is exploitable over network with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.
Is CVE-2014-5432 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 3% (83rd percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2014-5432?
CVE-2014-5432 affects Baxter Sigma Spectrum Infusion System Firmware. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2014-5432?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its critical severity, prioritise patching exposed systems.
When was CVE-2014-5432 published?
CVE-2014-5432 was published on 2019-03-26 and last updated on 2026-06-17.

References

Affected products (1)

More vulnerabilities in Baxter Sigma Spectrum Infusion System Firmware

All CVEs affecting Baxter Sigma Spectrum Infusion System Firmware →

Other CWE-287 (Improper Authentication) vulnerabilities

Browse all CWE-287 (Improper Authentication) vulnerabilities →